tariquidar has been researched along with astragaloside a in 1 studies
Studies (tariquidar) | Trials (tariquidar) | Recent Studies (post-2010) (tariquidar) | Studies (astragaloside a) | Trials (astragaloside a) | Recent Studies (post-2010) (astragaloside a) |
---|---|---|---|---|---|
210 | 16 | 138 | 675 | 5 | 573 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Huang, F; Lan, Y; Li, H; Liu, M; Shi, H; Wu, H; Wu, X; Yang, L; Zhang, B; Zhang, W | 1 |
1 other study(ies) available for tariquidar and astragaloside a
Article | Year |
---|---|
P-glycoprotein Inhibitor Tariquidar Potentiates Efficacy of Astragaloside IV in Experimental Autoimmune Encephalomyelitis Mice.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily G, Member 2; Blood-Brain Barrier; Cell Line; Drug Synergism; Encephalomyelitis, Autoimmune, Experimental; Endothelial Cells; Female; Mice; Molecular Conformation; Molecular Docking Simulation; Molecular Dynamics Simulation; Quinolines; Saponins; Substrate Specificity; Triterpenes | 2019 |